Search Results - "Samarpita, Snigdha"
-
1
Leveraging Exosomes as the Next-Generation Bio-Shuttles: The Next Biggest Approach against Th17 Cell Catastrophe
Published in International journal of molecular sciences (01-04-2023)“…In recent years, the launch of clinical-grade exosomes is rising expeditiously, as they represent a new powerful approach for the delivery of advanced…”
Get full text
Journal Article -
2
Investigation of toll-like receptor (TLR) 4 inhibitor TAK-242 as a new potential anti-rheumatoid arthritis drug
Published in Arthritis research & therapy (23-01-2020)“…Proper blocking of toll-like receptor (TLR) activation during disease progression has been reported to have inhibitory effect on the pathogenesis of rheumatoid…”
Get full text
Journal Article -
3
Majoon Chobchini attenuates arthritis disease severity and RANKL-mediated osteoclastogenesis in rheumatoid arthritis
Published in 3 Biotech (01-10-2021)“…Majoon Chobchini, a polyherbal Unani compound, has been used holistically in India to treat rheumatoid arthritis. However, the potential mechanism underlying…”
Get full text
Journal Article -
4
Selective blockade of IL-21 by myricetin impedes T follicular helper cell differentiation by negatively regulating the JAK/STAT/Bcl-6 pathway in a rheumatoid arthritis animal model
Published in 3 Biotech (2024)“…Interleukin (IL)-21 is a major lineage-defining factor that promotes Tfh cell differentiation. The current study investigated the molecular basis of myricetin,…”
Get full text
Journal Article -
5
Majoon chobchini reinstates PDL-1 expression and blocks dendritic cell -T helper 17 pathogenic axis in rheumatoid arthritis animal model
Published in Cytokine (Philadelphia, Pa.) (01-03-2023)“…Dendritic cells (DCs) are the critical players in the puzzle of rheumatoid arthritis (RA) disease pathogenesis. Blockade of DC activation has been shown to…”
Get full text
Journal Article -
6
Cyanidin attenuates IL-17A cytokine signaling mediated monocyte migration and differentiation into mature osteoclasts in rheumatoid arthritis
Published in Cytokine (Philadelphia, Pa.) (01-06-2021)“…•Cyanidin, a potent inhibitor of IL-17 signaling associated pathogenesis in RA.•Cyanidin modulates IL-17A/IL-17RA interaction.•Cyanidin blocks IL-17A/p38 MAPK…”
Get full text
Journal Article -
7
Cyanidin restores Th17/Treg balance and inhibits T follicular helper cell differentiation via modulation of ROCK2 signaling in an experimental model of rheumatoid arthritis
Published in International immunopharmacology (01-12-2021)“…•Cyanidin regulates Th17/Treg ratio and Tfh cell differentiation in RA.•Cyanidin reduced Tfh cell proportion and IgG levels in AIA rats.•Cyanidin upregulates…”
Get full text
Journal Article -
8
Cyanidin prevents the hyperproliferative potential of fibroblast-like synoviocytes and disease progression via targeting IL-17A cytokine signalling in rheumatoid arthritis
Published in Toxicology and applied pharmacology (15-03-2020)“…The hyperplastic phenotype of fibroblast-like synoviocytes (FLSs) plays an important role for synovitis, chronic inflammation and joint destruction in…”
Get full text
Journal Article -
9
Unleashing the pathological imprinting of cancer in autoimmunity: Is ZEB1 the answer?
Published in Life sciences (1973) (01-11-2023)“…The intriguing scientific relationship between autoimmunity and cancer immunology have been traditionally indulged to throw spotlight on novel pathological…”
Get full text
Journal Article -
10
Ferulic acid, a dietary polyphenol suppresses osteoclast differentiation and bone erosion via the inhibition of RANKL dependent NF-κB signalling pathway
Published in Life sciences (1973) (15-08-2018)“…Bone erosion induced by enhanced osteoclast formation is a debilitating pathological phenomenon in rheumatoid arthritis (RA). Recent finding has revealed that…”
Get full text
Journal Article -
11
Interleukin 17 under hypoxia mimetic condition augments osteoclast mediated bone erosion and expression of HIF-1α and MMP-9
Published in Cellular immunology (01-10-2018)“…•IL-17 and hypoxia promotes osteoclast mediated bone resorption in vitro.•IL-17 synergise with hypoxia to augment the expression of HIF-1α, MMP-9 and…”
Get full text
Journal Article -
12
CYT387 Inhibits the Hyperproliferative Potential of Fibroblast-like Synoviocytes via Modulation of IL-6/JAK1/STAT3 Signaling in Rheumatoid Arthritis
Published in Immunological investigations (18-08-2022)“…Fibroblast-like synoviocytes (FLS) are the critical effector cells primarily involved in rheumatoid arthritis (RA) disease pathogenesis. Interleukin (IL)-6, a…”
Get full text
Journal Article -
13
-
14
IL-17A/IL-17RA interaction blockade sensitizes synovial macrophages to efferocytosis and PD-L1 signaling via rewiring STAT-3/ADAM17/MERTK axis in rheumatoid arthritis animal model
Published in International immunopharmacology (30-07-2024)“…•Disruption of IL-17A interaction with IL-17RA restored efferocytosis in an adjuvant model of RA.•IL-17A suppressed efferocytosis via ADAM17 mediated cleavage…”
Get full text
Journal Article -
15
Ferulic acid, a dietary polyphenol suppresses osteoclast differentiation and bone erosion via the inhibition of RANKL dependent NF-?B signalling pathway
Published in Life sciences (1973) (15-08-2018)“…Aims Bone erosion induced by enhanced osteoclast formation is a debilitating pathological phenomenon in rheumatoid arthritis (RA). Recent finding has revealed…”
Get full text
Journal Article -
16
8-Shogaol inhibits rheumatoid arthritis through targeting TAK1
Published in Pharmacological research (01-04-2022)“…Rheumatoid arthritis (RA) is a chronic immune-mediated disorder, mainly characterized by synovial inflammation and joint damage. If insufficiently treated, RA…”
Get full text
Journal Article -
17
PdCl2-catalyzed synthesis of a new class of isocoumarin derivatives containing aminosulfonyl / aminocarboxamide moiety: First identification of a isocoumarin based PDE4 inhibitor
Published in European journal of medicinal chemistry (05-10-2021)“…While anti-inflammatory properties of isocoumarins are known their PDE4 inhibitory potential was not explored previously. In our effort the non-PDE4 inhibitor…”
Get full text
Journal Article -
18
Targeting next-generation PDE4 inhibitors in search of potential management of rheumatoid arthritis and psoriasis
Published in Bioorganic chemistry (01-10-2024)“…The in silico, in vitro and in vivo evaluation of a new class of isoquinolone derivatives afforded compound 1l as the next-generation PDE4 inhibitor that can…”
Get full text
Journal Article -
19
Fe(III)-catalyzed regioselective and faster synthesis of isocoumarins with 3-oxoalkyl moiety at C-4: Identification of new inhibitors of PDE4
Published in Bioorganic chemistry (01-04-2022)“…[Display omitted] •The inexpensive FeCl3 afforded regioselective and faster synthesis of isocoumarins.•Isocoumarins with 3-oxoalkyl moiety at C-4 showed potent…”
Get full text
Journal Article -
20
PdCl 2 -catalyzed synthesis of a new class of isocoumarin derivatives containing aminosulfonyl / aminocarboxamide moiety: First identification of a isocoumarin based PDE4 inhibitor
Published in European journal of medicinal chemistry (05-10-2021)“…While anti-inflammatory properties of isocoumarins are known their PDE4 inhibitory potential was not explored previously. In our effort the non-PDE4 inhibitor…”
Get full text
Journal Article